Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil

Showing results (31-40 of 11,761) with videos related to

Pageof 1,177
Sort By:
Materials (Basel, Switzerland)|July 28, 2022
Correlation of Bone Material Model Using Voxel Mesh and Parametric OptimizationKamil Pietroń, Łukasz Mazurkiewicz, Kamil Sybilski, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 30, 2006
New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarinMartina Hrabinova, Kamil Musilek, Daniel Jun, et al.
Journal of Separation Science|August 22, 2014
Structural modifications of dicationic acetylcholinesterase reactivators studied under ion-pairing mechanism in reversed-phase liquid chromatographyMedeea Radulescu, Kamil Kuca, Kamil Musilek, et al.
Expert Opinion on Drug Discovery|September 28, 2012
The progress in the cholinesterase quantification methodsOndrej Holas, Kamil Musilek, Miroslav Pohanka, et al.
Toxicology|December 7, 2007
An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and miceJiri Kassa, Jana Karasova, Kamil Musilek, et al.
Materials (Basel, Switzerland)|August 28, 2025
The Influence of Starting Plant Material on Ni@C-Type Composites' CharacteristicsKamil Dudek, Stanisław Małecki, Kamil Kornaus, et al.
Mini Reviews in Medicinal Chemistry|October 16, 2008
The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabunJiri Kassa, Kamil Kuca, Jana Karasova, et al.
International Journal of Molecular Sciences|June 16, 2011
In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesteraseDaniel Jun, Lucie Musilova, Kamil Musilek, et al.
Journal of Clinical Medicine|September 27, 2025
Current and Emerging Sedation Practices for Colonoscopy: A Narrative Review of Pharmacological Agents, High-Risk Populations, and Safety ConsiderationsKamil Chudziński, Konstanty Szułdrzyński, Miłosz Jankowski, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 4, 2016
[Lactobacillus fermentum CECT5716 - probiotic from human milk with interesting properties]Kamil Żarłok
Pageof 1,177

Showing results (31-40 of 11,761) with videos related to

Sort By:
Pageof 1,177
Materials (Basel, Switzerland)|July 28, 2022
Correlation of Bone Material Model Using Voxel Mesh and Parametric OptimizationKamil Pietroń, Łukasz Mazurkiewicz, Kamil Sybilski, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 30, 2006
New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarinMartina Hrabinova, Kamil Musilek, Daniel Jun, et al.
Journal of Separation Science|August 22, 2014
Structural modifications of dicationic acetylcholinesterase reactivators studied under ion-pairing mechanism in reversed-phase liquid chromatographyMedeea Radulescu, Kamil Kuca, Kamil Musilek, et al.
Expert Opinion on Drug Discovery|September 28, 2012
The progress in the cholinesterase quantification methodsOndrej Holas, Kamil Musilek, Miroslav Pohanka, et al.
Toxicology|December 7, 2007
An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and miceJiri Kassa, Jana Karasova, Kamil Musilek, et al.
Materials (Basel, Switzerland)|August 28, 2025
The Influence of Starting Plant Material on Ni@C-Type Composites' CharacteristicsKamil Dudek, Stanisław Małecki, Kamil Kornaus, et al.
Mini Reviews in Medicinal Chemistry|October 16, 2008
The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabunJiri Kassa, Kamil Kuca, Jana Karasova, et al.
International Journal of Molecular Sciences|June 16, 2011
In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesteraseDaniel Jun, Lucie Musilova, Kamil Musilek, et al.
Journal of Clinical Medicine|September 27, 2025
Current and Emerging Sedation Practices for Colonoscopy: A Narrative Review of Pharmacological Agents, High-Risk Populations, and Safety ConsiderationsKamil Chudziński, Konstanty Szułdrzyński, Miłosz Jankowski, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|August 4, 2016
[Lactobacillus fermentum CECT5716 - probiotic from human milk with interesting properties]Kamil Żarłok
Pageof 1,177